Mínimo 3 entidades de 3 países
Biomarkers are invaluable tools for improving patient outcomes, guiding treatment decisions, accelerating personalised medicine, more effective clinical research and the development of better medicines.
Ver en el portal de la ComisiónFuente:Portal Funding & Tenders (Comisión Europea), actualizado el 31 oct 2026